DYSMYELINATION IN TRANSGENIC MICE RESULTING FROM EXPRESSION OF CLASS-I HISTOCOMPATIBILITY MOLECULES IN OLIGODENDROCYTES

被引:103
作者
TURNLEY, AM [1 ]
MORAHAN, G [1 ]
OKANO, H [1 ]
BERNARD, O [1 ]
MIKOSHIBA, K [1 ]
ALLISON, J [1 ]
BARTLETT, PF [1 ]
MILLER, JFAP [1 ]
机构
[1] OSAKA UNIV,INST PROT RES,OSAKA 565,JAPAN
关键词
D O I
10.1038/353566a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MAJOR histocompatibility complex (MHC) molecules are not normally expressed in the central nervous system (CNS) 1-3. However, aberrant expression has been observed in multiple sclerosis lesions and could contribute to the destruction of myelin or the myelinating cells known as oligodendrocytes 4,5. The mechanism of cell damage associated with aberrant MHC molecule expression is unclear: for example, overexpression of class I (ref. 6) and class II (refs 7, 8) MHC molecules in pancreatic beta-cells in transgenic mice leads to nonimmune destruction of the cells and insulin-dependent diabetes mellitus. We have generated transgenic mice that express class I H-2K(b) MHC molecules, under the control of the myelin basic protein promoter, specifically in oligodendrocytes. Homozygous transgenic mice have a shivering phenotype, develop tonic seizures and die at 15-22 days. This phenotype, which we term 'wonky', is due to hypomyelination in the CNS, and not to involvement of the immune system. The primary defect appears to be a shortage of myelinating oligodendrocytes resulting from overexpression of the class I MHC molecules.
引用
收藏
页码:566 / 569
页数:4
相关论文
共 26 条
[1]   DIABETES IN TRANSGENIC MICE RESULTING FROM OVER-EXPRESSION OF CLASS-I HISTOCOMPATIBILITY MOLECULES IN PANCREATIC BETA-CELLS [J].
ALLISON, J ;
CAMPBELL, IL ;
MORAHAN, G ;
MANDEL, TE ;
HARRISON, LC ;
MILLER, JFAP .
NATURE, 1988, 333 (6173) :529-533
[2]  
BARTLETT PF, 1983, J CLIN LAB IMMUNOL, V11, P1
[3]  
BARTLETT PF, 1989, TRANSPLANT P, V21, P3166
[4]   DETECTION OF VARIOUS FORMS OF BRAIN MYELIN BASIC-PROTEIN IN VERTEBRATES BY ELECTROIMMUNOBLOTTING [J].
DEROSBO, NK ;
CARNEGIE, PR ;
BERNARD, CCA ;
LINTHICUM, DS .
NEUROCHEMICAL RESEARCH, 1984, 9 (10) :1359-1369
[5]   IMMUNE-DEFICIENCY DUE TO HIGH COPY NUMBERS OF AN A BETA-KAPPA-TRANSGENE [J].
GILFILLAN, S ;
AISO, S ;
MICHIE, SA ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7319-7323
[6]   INCORPORATION OF GLYCOPROTEINS INTO PERIPHERAL-NERVE MYELIN [J].
GOULD, RM .
JOURNAL OF CELL BIOLOGY, 1977, 75 (02) :326-338
[7]  
JONESYOUNGBLOOD SL, 1990, J IMMUNOL, V144, P1187
[8]   AXONS MODULATE MYELIN PROTEIN MESSENGER-RNA LEVELS DURING CENTRAL-NERVOUS-SYSTEM MYELINATION INVIVO [J].
KIDD, GJ ;
HAUER, PE ;
TRAPP, BD .
JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 26 (04) :409-418
[9]   DIABETES AND TOLERANCE IN TRANSGENIC MICE EXPRESSING CLASS-II MHC MOLECULES IN PANCREATIC BETA-CELLS [J].
LO, D ;
BURKLY, LC ;
WIDERA, G ;
COWING, C ;
FLAVELL, RA ;
PALMITER, RD ;
BRINSTER, RL .
CELL, 1988, 53 (01) :159-168
[10]   MULTIPLE-SCLEROSIS .1. [J].
MCFARLIN, DE ;
MCFARLAND, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (19) :1183-1188